International developed-market equities continue to serve as a foundational element for investors looking to diversify beyond U.S. large-cap holdings. Comparing FENI and VEA provides useful perspective, as both target similar objectives around non-U.S. developed markets yet follow distinct approaches. FENI applies an active, research-driven overlay of factor tilts to the MSCI EAFE benchmark, while VEA delivers low-cost, full-replication exposure across thousands of securities. These differences help clarify whether active enhancement merits the added expense or if passive breadth offers a stronger base for risk-adjusted results.
FENI operates as an actively managed ETF that typically commits at least 80% of assets to common stocks in the MSCI EAFE Index, which covers developed-market equities outside the U.S. and Canada. The adviser uses a quantitative, research-based method focused on long-term drivers including valuation, growth, and quality. The fund maintains around 450 holdings with a 0.28% expense ratio and tends to favor large-cap names. Leading positions include ASML Holding, Roche Holding, Nestlé, Siemens, Novartis, HSBC, Tokyo Electron, and UBS Group. Sector weights emphasize financials at roughly 24%, industrials near 22%, and technology around 11–12%, alongside notable healthcare exposure. Japan leads geographic allocations at about 23%, followed by the U.K., France, Germany, the Netherlands, and Switzerland. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
VEA tracks the FTSE Developed All Cap ex US Index through a passive, full-replication strategy. The benchmark covers approximately 3,900 large-, mid-, and small-cap companies in Canada along with major European and Pacific markets. The fund holds securities in proportions matching the index and maintains an expense ratio of just 0.03%. Top holdings feature Samsung Electronics, SK hynix, ASML Holding, HSBC, Roche Holding, Royal Bank of Canada, Novartis, Shell, and Nestlé. Sector allocations highlight financials near 24%, industrials about 18%, and technology around 13%, with healthcare and consumer discretionary also prominent. Inclusion of Canada creates somewhat different country exposure than EAFE-focused peers, with Japan, the U.K., and Canada as the largest weights.
Both ETFs operate in the international developed-markets equity space, influenced by ongoing cycles such as artificial-intelligence and semiconductor capital spending that support names like ASML, Samsung Electronics, SK hynix, and Tokyo Electron. Monetary-policy differences across central banks and currency fluctuations involving the U.S. dollar, euro, yen, and pound also play roles. European financials have gained from higher-for-longer rates, while Japanese equities have drawn interest amid governance reforms. Risks encompass currency swings, geopolitical issues, regulatory changes in technology, and potential trade slowdowns. These factors affect both funds but manifest differently: VEA spreads exposure across thousands of holdings, whereas FENI concentrates similar themes through active tilts.
Recent performance for both FENI and VEA has largely followed broader international developed-market patterns, with differences stemming more from structure than market direction. VEA benefits from its lower fee, wider diversification, and greater weight in semiconductor leaders such as Samsung Electronics and SK hynix, which aided resilience in technology-driven periods while thousands of holdings limit single-stock exposure. FENI’s active tilts toward European industrials and healthcare can influence relative results during sector rotations, though higher turnover and factor selection create more tracking variation versus its benchmark. From what I see, VEA’s scale and trading depth deliver tighter spreads and reduced structural risk compared with FENI’s more concentrated, actively managed approach.
In my research process, I occasionally turn to Tickeron’s AI Screener to quickly compare structural features across ETFs like these two. The tool allows filtering on factors such as expense ratios, holdings count, sector weights, and liquidity metrics, which helps surface relative strengths without manual effort. I also referenced the AI Daily Buy/Sell Signals for a quick view of recent trend consistency. These steps support a more data-driven assessment before forming a final view on allocation choices.
After reviewing the structural details, I think VEA stands out over FENI on balance. The 0.03% expense ratio versus 0.28% creates a lasting cost edge that compounds meaningfully over time, and the roughly 3,900 holdings deliver broader diversification with less single-name concentration. VEA further benefits from stronger liquidity, higher trading volume, and the clarity of a full-replication passive mandate that lowers tracking error and manager risk. While FENI’s active factor tilts may add value in certain rotations, that comes with elevated fees and more variability. On balance, the edge favors VEA for consistent, cost-efficient exposure to developed international markets in the current setting.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
VEA saw its Momentum Indicator move below the 0 level on November 16, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 78 similar instances where the indicator turned negative. In 66 of the 78 cases, the stock moved further down in the following days. The odds of a decline are at 85%.
The Moving Average Convergence Divergence Histogram (MACD) for VEA turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 38 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VEA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Aroon Indicator for VEA entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +0.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where VEA advanced for three days, in 266 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
VEA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows